NCT05567094View on ClinicalTrials.gov

The Effect of Perioperative DEXamethasone on Postoperative Complications After PANcreaticoduodenectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 8, 2022

Primary Completion Date

September 14, 2023

Study Completion Date

September 14, 2023

Conditions
Pancreaticoduodenectomy
Interventions
DRUG

Dexamethasone

Patients will receive 0.2 mg/kg dexamethasone, administered as an intravenous bolus within 5 minutes after induction of anesthesia

DRUG

Saline placebo

Patients will receive 2ml saline placebo, administered as an intravenous bolus within 5 minutes after induction of anesthesia

Trial Locations (1)

200025

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER